Related Experiment Video

Updated: Jun 1, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
06:04

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation

Published on: August 8, 2025

[Antithrombotic therapy after heart valve surgery--current evidence and future trends]

Miroslava Benesová1

  • 1Kardiochirurgické oddelení Nemocnice Na Homolce, Praha. miroslava.benesova@homolka.cz

Casopis Lekaru Ceskych
|June 4, 2011
PubMed

Insights

Degenerative valve disease is increasing, necessitating careful drug therapy selection after heart valve replacement surgery. This review assesses anticoagulation and antiplatelet therapies based on expert guidelines.

Area of Science:

  • Cardiology and Cardiovascular Surgery
  • Pharmacology and Therapeutics

Context:

  • Degenerative valve disease is a growing global health concern, particularly among the elderly.
  • Over 300,000 prosthetic heart valve replacements are performed annually worldwide, with projections reaching 850,000 by 2050.
  • Increased risk of thromboembolic events post-heart valve surgery necessitates pharmacotherapy.

Purpose:

  • To review and assess the benefits and risks of various anticoagulation and antiplatelet therapy schemes for patients undergoing heart valve replacement.
  • To provide guidance on drug therapy selection based on surgical type and individual patient risk factors.

Summary:

  • Heart valve replacement surgery is increasing, especially in elderly populations.
  • Anticoagulation and antiplatelet therapies are crucial post-surgery to mitigate thromboembolic risks.
  • Therapy selection is individualized, considering surgery type and patient-specific risk profiles.

Impact:

  • Informs clinical decision-making for cardiologists and cardiac surgeons regarding optimal pharmacotherapy post-valve replacement.
  • Contributes to improved patient outcomes by guiding evidence-based treatment strategies.
  • Highlights the importance of adhering to guidelines from major cardiology and cardiosurgery associations.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...